×
S&P 500   3,783.08 (-0.06%)
DOW   30,784.83 (+0.03%)
QQQ   278.37 (-0.68%)
AAPL   136.81 (+0.07%)
MSFT   256.56 (-0.11%)
META   157.01 (-2.63%)
GOOGL   2,140.18 (-1.79%)
AMZN   107.90 (+1.59%)
TSLA   668.78 (-0.69%)
NVDA   144.23 (-4.86%)
NIO   21.11 (-2.81%)
BABA   115.22 (+1.35%)
AMD   73.16 (-4.33%)
MU   52.63 (-4.79%)
CGC   2.87 (+0.70%)
T   21.07 (+0.52%)
GE   63.07 (-0.94%)
F   11.16 (+0.27%)
DIS   94.85 (+0.48%)
AMC   13.36 (-1.40%)
PFE   51.51 (-1.75%)
PYPL   70.30 (+0.66%)
NFLX   176.09 (+0.70%)
S&P 500   3,783.08 (-0.06%)
DOW   30,784.83 (+0.03%)
QQQ   278.37 (-0.68%)
AAPL   136.81 (+0.07%)
MSFT   256.56 (-0.11%)
META   157.01 (-2.63%)
GOOGL   2,140.18 (-1.79%)
AMZN   107.90 (+1.59%)
TSLA   668.78 (-0.69%)
NVDA   144.23 (-4.86%)
NIO   21.11 (-2.81%)
BABA   115.22 (+1.35%)
AMD   73.16 (-4.33%)
MU   52.63 (-4.79%)
CGC   2.87 (+0.70%)
T   21.07 (+0.52%)
GE   63.07 (-0.94%)
F   11.16 (+0.27%)
DIS   94.85 (+0.48%)
AMC   13.36 (-1.40%)
PFE   51.51 (-1.75%)
PYPL   70.30 (+0.66%)
NFLX   176.09 (+0.70%)
S&P 500   3,783.08 (-0.06%)
DOW   30,784.83 (+0.03%)
QQQ   278.37 (-0.68%)
AAPL   136.81 (+0.07%)
MSFT   256.56 (-0.11%)
META   157.01 (-2.63%)
GOOGL   2,140.18 (-1.79%)
AMZN   107.90 (+1.59%)
TSLA   668.78 (-0.69%)
NVDA   144.23 (-4.86%)
NIO   21.11 (-2.81%)
BABA   115.22 (+1.35%)
AMD   73.16 (-4.33%)
MU   52.63 (-4.79%)
CGC   2.87 (+0.70%)
T   21.07 (+0.52%)
GE   63.07 (-0.94%)
F   11.16 (+0.27%)
DIS   94.85 (+0.48%)
AMC   13.36 (-1.40%)
PFE   51.51 (-1.75%)
PYPL   70.30 (+0.66%)
NFLX   176.09 (+0.70%)
S&P 500   3,783.08 (-0.06%)
DOW   30,784.83 (+0.03%)
QQQ   278.37 (-0.68%)
AAPL   136.81 (+0.07%)
MSFT   256.56 (-0.11%)
META   157.01 (-2.63%)
GOOGL   2,140.18 (-1.79%)
AMZN   107.90 (+1.59%)
TSLA   668.78 (-0.69%)
NVDA   144.23 (-4.86%)
NIO   21.11 (-2.81%)
BABA   115.22 (+1.35%)
AMD   73.16 (-4.33%)
MU   52.63 (-4.79%)
CGC   2.87 (+0.70%)
T   21.07 (+0.52%)
GE   63.07 (-0.94%)
F   11.16 (+0.27%)
DIS   94.85 (+0.48%)
AMC   13.36 (-1.40%)
PFE   51.51 (-1.75%)
PYPL   70.30 (+0.66%)
NFLX   176.09 (+0.70%)
NYSE:CLB

Core Laboratories Stock Forecast, Price & News

$19.61
-0.20 (-1.01%)
(As of 07/1/2022 01:19 PM ET)
Add
Compare
Today's Range
$18.66
$19.87
50-Day Range
$18.66
$31.02
52-Week Range
$18.41
$40.97
Volume
6,115 shs
Average Volume
506,647 shs
Market Capitalization
$908.10 million
P/E Ratio
93.38
Dividend Yield
0.20%
Price Target
$29.43
30 days | 90 days | 365 days | Advanced Chart

Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

CLB Stock Forecast (MarketRank)

Overall MarketRank

2.35 out of 5 stars

Oils/Energy Sector

116th out of 391 stocks

Oil & Gas Field Services, Not Elsewhere Classified Industry

10th out of 32 stocks

Analyst Opinion: 2.7Community Rank: 3.9Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
Core Laboratories logo

About Core Laboratories (NYSE:CLB)

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.

CLB Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Oil & gas field services, not elsewhere classified
Sub-Industry
N/A
Fax
N/A
Employees
3,700
Year Founded
1936

Company Calendar

Last Earnings
4/27/2022
Ex-Dividend for 5/31 Dividend
5/06/2022
Dividend Payable
5/31/2022
Today
7/01/2022
Next Earnings (Confirmed)
7/27/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$29.43
High Stock Price Forecast
$35.00
Low Stock Price Forecast
$21.30
Forecasted Upside/Downside
+50.1%
Consensus Rating
Reduce
Rating Score (0-4)
1.33333333333333
Research Coverage
3 Analysts

Profitability

Net Income
$19.73 million
Pretax Margin
4.78%

Debt

Sales & Book Value

Annual Sales
$470.25 million
Cash Flow
$1.15 per share
Book Value
$3.48 per share

Miscellaneous

Free Float
46,114,000
Market Cap
$908.10 million
Optionable
Optionable
Beta
2.71

Social Links















Core Laboratories Frequently Asked Questions

Should I buy or sell Core Laboratories stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "reduce" Core Laboratories stock.
View analyst ratings for Core Laboratories
or view top-rated stocks.

What is Core Laboratories' stock price forecast for 2022?

3 Wall Street analysts have issued 12-month price objectives for Core Laboratories' stock. Their CLB stock forecasts range from $21.30 to $35.00. On average, they anticipate Core Laboratories' stock price to reach $29.43 in the next year. This suggests a possible upside of 50.6% from the stock's current price.
View analysts' price targets for Core Laboratories
or view top-rated stocks among Wall Street analysts.

How has Core Laboratories' stock performed in 2022?

Core Laboratories' stock was trading at $22.31 at the start of the year. Since then, CLB stock has decreased by 12.4% and is now trading at $19.54.
View the best growth stocks for 2022 here
.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022.
View our earnings forecast for Core Laboratories
.

How can I listen to Core Laboratories' earnings call?

Core Laboratories will be holding an earnings conference call on Thursday, July 28th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) released its quarterly earnings results on Wednesday, April, 27th. The oil and gas company reported $0.08 EPS for the quarter, beating the consensus estimate of $0.06 by $0.02. The oil and gas company had revenue of $115.30 million for the quarter, compared to the consensus estimate of $111.63 million. Core Laboratories had a net margin of 2.04% and a trailing twelve-month return on equity of 18.28%. During the same period in the previous year, the firm posted $0.15 earnings per share.
View Core Laboratories' earnings history
.

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories announced a quarterly dividend on Wednesday, April 27th. Stockholders of record on Monday, May 9th will be paid a dividend of $0.01 per share on Tuesday, May 31st. This represents a $0.04 annualized dividend and a dividend yield of 0.20%. The ex-dividend date is Friday, May 6th.
View Core Laboratories' dividend history
.

Is Core Laboratories a good dividend stock?

Core Laboratories(NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.20%. The dividend payout ratio of Core Laboratories is 19.05%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 2.99% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.
View Core Laboratories' dividend history.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories updated its first quarter 2022 earnings guidance on Wednesday, April, 13th. The company provided EPS guidance of $0.050-$0.080 for the period, compared to the consensus estimate of $0.200. The company issued revenue guidance of $110 million-$113 million, compared to the consensus revenue estimate of $110.23 million.

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the following people:
  • Mr. Lawrence V. Bruno, Chairman, CEO, Pres & COO (Age 62, Pay $1.61M)
  • Mr. Christopher Scott Hill, Sr. VP & CFO (Age 52, Pay $702.65k)
  • Ms. Gwendolyn Y. Gresham M.B.A., Sr. VP of Corp. Devel. & Investor Relations (Age 54, Pay $612.71k)
  • Mr. Mark Damian Tattoli, Sr. VP, Sec. & Gen. Counsel (Age 50, Pay $948.9k)
  • Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 58)
  • Mr. Jacobus Schouten, Managing Director (Age 67)
  • J. Donald Dumas Jr., Sr. VP of Production Enhancement & Bus. Devel.

What is David M. Demshur's approval rating as Core Laboratories' CEO?

60 employees have rated Core Laboratories CEO David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among Core Laboratories' employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $19.54.

How much money does Core Laboratories make?

Core Laboratories (NYSE:CLB) has a market capitalization of $904.86 million and generates $470.25 million in revenue each year. The oil and gas company earns $19.73 million in net income (profit) each year or $0.21 on an earnings per share basis.

How many employees does Core Laboratories have?

Core Laboratories employs 3,700 workers across the globe.

When was Core Laboratories founded?

Core Laboratories was founded in 1936.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for Core Laboratories is www.corelab.com. The oil and gas company can be reached via phone at (120) 420-3191 or via email at [email protected].

This page (NYSE:CLB) was last updated on 7/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.